InvestorsHub Logo
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 603

Monday, 04/25/2022 10:32:50 AM

Monday, April 25, 2022 10:32:50 AM

Post# of 870
CHMP approves Keytruda/chemo in the neoadjuvant setting followed by Keytruda monotherapy in the adjuvant setting for non-metastatic TNBC:

https://www.businesswire.com/news/home/20220425005161/en

Approval based on KEYNOTE-522 trial.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News